Point cloud fusion instance effect. by Hongliang Zou (20707270)

Subjects:

S1 Data - by Emma Nixon (11772946)

Subjects:

Daily change in bodyweight from baseline over the course of the study, where day 0 is when catheters and ISF probes were placed, and day 3 is the day of processing. by Emma Nixon (11772946)

Subjects:

Genes showing 1.5 fold expression decrease in D381 relative to heterozygous <i>TOR1/tor1</i>. by Wanjun Qi (5571359)

V3Nter decreases colony formation and induces tumor cell death in HCT116 and HepG2 cells. by Delphine Quélard (43727)

Proviral load in blood was decreased in HTLV-1 infected CD133+ Hu-mice when vCTCF-BS was deleted. by Ancy Joseph (5634794)

Data_Sheet_5_Chronic Neurobehavioral Impairments and Decreased Hippocampal Expression of Genes Important for Brain Glucose Utilization in a Mouse Model of Mild TBI.xlsx by Linda M. Huynh (9395591)

Klf5 and eIF5a suppress Ang II–induced expression of NOX1 in VSMCs. by Dong Ma (584680)

Subjects:

Cycloheximide (CHX) treatment decreases production of rRNA transcripts by POLR1 and POLR3. by Martin Selinger (3195987)

“…<p>(A) DAOY cells were treated with CHX (100 μg/ml) for either 6 or 14 hours; for metabolic RNA labelling, 5-EU was added 2 hours before the sample collection. …”

Oral administration of PEITC stimulates leptin signaling in the hypothalamus. by Miho Yagi (5921252)

LOH at <i>KSR1</i> affects cellular lipid profiles, intracellular FLC concentrations, drug efflux, and sterol levels. by Pétra Vande Zande (17628246)

Pharmacokinetic analysis of LY5 in mice and normal dogs. by Peter Y. Yu (4281448)

Step-wise evolution of drug resistance via CNV and LOH. by Pétra Vande Zande (17628246)

Effects of SNPs on the Protein Stability, Increasing or Decreasing. by Mirza Jawad Ul Hasnain (8351388)

Fig 5 - by Elizabeth A. Moore (18083377)

Fx controls the TNF-enhanced Ser/5-HT-promoted <i>Trypanosoma cruzi</i> uptake by U-87 MG cells and neuromediators availability. by Glaucia Vilar-Pereira (686134)

Subjects:

Fig 10 - by Sana Khalid (132742)

Fig 5 - by Sheona Isobel Shankland (19976311)

Validation of primary screen hits reveals compounds that recapitulate increased spheroid size (swell) or decreased MUC5AC in the lumen. by Pranjali Beri (14945400)

“…Compounds that appeared to cause toxicity were identified by observing a significant decrease in spheroid counts in the swell readout or a significant decrease in the total nuclear intensity of the MUC5AC ratio readout. …”

EGCG treatment decreases TTR deposition and associated biomarkers in the gastrointestinal tract of old hTTR V30M mice. by Nelson Ferreira (188837)